Sustained Effort Network for Treatment of Status Epilepticus/European Academy of Neurology Registry on Refractory Status Epilepticus (SENSE-II/AROUSE)
Recruiting now
Conditions studied: Status Epilepticus
In brief
SENSE-II/AROUSE is a prospective, multicenter registry for patients treated for SE. The primary objective is to document patients and SE characteristics, treatment modalities, EEG features, and outcome of consecutive adults admitted fir SE treatment in each of the participating centers and to identify predictors of outcome and refractoriness.
Key facts
- Study ID
- NCT05839418
- Run by
- Erasme University Hospital
- People needed
- 3000
- Starts
- 2023-03-01
- Expected to finish
- 2028-12-31
- Last updated by the study team
- 2023-05-03
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Patients aged 18 years or above
- Patients admitted for management of Status Epilepticus as their primary diagnosis
- Patients admitted for another primary diagnosis but identified with Status Epilepticus during their acute hospital stay
You may not qualify if…
- Patients with post-cardiac arrest SE
Where it is running
- Odense University Hospital & Svenborg Hospital — Odense, Denmark (enrolling)
- HUB Erasme — Brussels, Belgium (enrolling)
- Helsinki University Central Hospital — Helsinki, Finland
- Goethe-Universität Frankfurt am Main — Frankfurt, Germany
- Epilepsy Center Münster-Osnabrück, Klinikum Osnabrück — Osnabrück, Germany
- Oslo University Hospital — Oslo, Norway
- University Hospital Basel — Basel, Switzerland
- University Hospital of Geneva — Geneva, Switzerland
- Kepler University Linz — Linz, Austria
- Birmingham University Hospitals NHS Trust — Birmingham, United Kingdom
- Christian Doppler Klinik of Paracelsus Medical University — Salzburg, Austria
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.